Quantcast
Last updated on April 21, 2014 at 5:21 EDT

Latest Industry of China Stories

2012-08-14 06:29:31

New subsidiary should enable the Company to speed-up growth in European markets MONTREAL, Aug. 14, 2012 /CNW Telbec/ - Clemex Technologies Inc. (TSXV: CXG.A) is pleased to announce the opening of its subsidiary "Clemex Europe" in France. This new subsidiary will be owned jointly by Clemex Technologies Inc. (75%) and RAL Diagnostics (25%). It will be located in Martillac (Bordeaux) and operated from the office premises of RAL Diagnostics. This expansion in Europe is in accordance...

2012-08-14 02:24:27

BRUSSELS, Aug. 14, 2012 /PRNewswire/ -- China's Permanent Green Energy Fund and The Europe China Foundation have signed an exclusive agency agreement in Tianjin, which would allow The Europe China Foundation to find investors for the PGEF outside of China. The groundbreaking agreement which would guarantee to the investor a minimum of 8% dividends, has whet the appetite of major banking institutions in the west, and has EU bankers vying for the chance to be the exclusive broker in...

2012-08-13 02:25:58

NEW YORK, Aug. 13, 2012 /PRNewswire/ -- Dr. Fischer, the global pharmaceutical company based in Israel, said today it will send a letter to Pediatricians, Ophthalmologists and Pharmacists notifying them that its baby eyelid wipes have been available for some time at U.S. pharmacies contrary to what an eye-care competitor is saying in advertising about its baby eyelid & eyelash cleanser being the "first and only" such wipes in the U.S. market. Not only does it plan to correct the record,...

2012-08-10 10:22:46

SAN DIEGO, Aug. 10, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's Chief Commercial Officer, Scott Byrd, will present the company's corporate overview on Tuesday, August 14, 2012 at 1:20pm Eastern Time (10:20am Pacific Time) during the Wedbush PACGROW Life Sciences Management...

2012-08-08 10:25:08

SEOUL, South Korea and NEW YORK, Aug. 8, 2012 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. and Green Cross Corp. (006280:Korea SE), a leading biotechnology company in South Korea, signed a Memorandum of Understanding (MOU) towards establishing their strategic collaboration surrounding the development and commercialization of Aquavit's IBX-001 in Asia. The MOU signing took place at Green Cross in Seoul Korea on July 31, 2012. The MOU includes the framework for their collaboration...

2012-08-02 06:24:20

Savings Reached $193 Billion in 2011, a Rate of $1 Billion Every Other Day WASHINGTON, Aug. 2, 2012 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA) today released an independently conducted analysis showing that the savings to consumers and the U.S. health care system from the use of generic prescription drugs has risen to a current rate of $1 billion every other day -- totaling $193 billion in 2011 and more than $1 trillion over the last 10 years (2002-2011)....

2012-08-01 02:28:39

ALISO VIEJO, Calif., Aug. 1, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter ended June 30, 2012, after market close on Wednesday August 8, 2012. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day. Conference Call Information:Domestic callers: 1 (888) 396-2298International callers: +1 (617) 847-8708Passcode: 62935757 Webcast information: Visit...

2012-07-31 06:22:26

BEIJING, July 31, 2012 /PRNewswire-Asia/ -- Huaneng Power International, Inc. ("HPI", the "Company") (NYSE: HNP; HKEx: 902; SSE: 600011) today announced its unaudited operating results for the six months ended June 30, 2012. For the six months ended June 30, 2012, the Company and its subsidiaries recorded consolidated operating revenue of RMB 67.180 billion (equivalent to approximately USD 10.622 billion based on the USD-RMB exchange rate of USD 1 to RMB 6.3249 as of June 30,...

2012-07-31 02:26:55

SONOMA, Calif., July 31, 2012 /PRNewswire/ -- When deciding how to treat common ailments such as arthritis, migraines, eczema, psoriasis, acne, or toe nail fungus, millions of Americans are looking for non-toxic alternatives to traditional pharmaceuticals. Instead of relying on chemical-filled or steroid-laced drugs that can often trigger harmful side effects, many are now choosing organic medicines to treat and heal their health conditions. Forces of Nature(® )offers more than 50...

2012-07-26 23:00:05

Enthusiasm among sexual dysfunction specialists for this breakthrough product in the treatment of male premature ejaculation is generating increasing demand from urologists, gynecologists and general practitioners. Huntington Beach, CA (PRWEB) July 26, 2012 Absorption Pharmaceuticals, LLC today announced the hiring of four key sales executives to meet the growing demand for Promescent® - the most effective medical solution for treating male premature ejaculation (PE). Jay Lovin, hired...